Clinical Trials
20 trialsTo Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Unidade Local de Saúde São João
"Cancersensor" Chemotherapy
Institut National de la Santé Et de la Recherche Médicale, France
"Cancersensor": Circadian Rhythms
Institut National de la Santé Et de la Recherche Médicale, France
MB
St. Borbala Hospital
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
CoSMIC
Manchester University NHS Foundation Trust
CRC
Institute for Clinical and Experimental Medicine
"Cancersensor" Metastasis Resection
Institut National de la Santé Et de la Recherche Médicale, France
ERBIFORT
National Cancer Institute, France
Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer
Ministry of Science and Technology of the People´s Republic of China
Dux
Austin Health
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
National Cancer Center, Korea
TIROX2
National Cancer Center, Korea
S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
National Cancer Center, Korea
Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
National Cancer Center, Korea
Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer
National Cancer Center, Korea
Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer
National Cancer Center, Korea
TIROX
National Cancer Center, Korea
TIROX2
National Cancer Center, Korea
Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan
National Cancer Center, Korea